𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer

✍ Scribed by Hei-Cheul Jeung; Sun Young Rha; Sung Hoon Noh; Jae Kyung Roh; Hyun Cheol Chung


Publisher
Springer
Year
2006
Tongue
English
Weight
308 KB
Volume
59
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II trial of irinotecan, cisplatin
✍ Dean A. Fennell; Jeremy P.C. Steele; Jonathan Shamash; Sarah E. Slater; Michael πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 87 KB πŸ‘ 1 views

## Abstract There is no standard therapy for relapsed small cell lung cancer (rSCLC). We evaluated the efficacy and toxicity of a new triplet consisting of irinotecan (100 mg/m^2^ Days 1 and 15 q28), cisplatin (40 mg/m^2^ Days 1 and 15 q28) and mitomycin (6 mg/m^2^ d1 q28) administered to a maximum